GlassScriptPhysician profile
Mary E Adams
NPI 1225399777
$35,886.10
in general payments reported to CMS, 2019-2025
8 companies · $9,818 in 2025
The $9,818 reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $425 · 2023: $13K · 2024: $12K · 2025: $9,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $1,003 · Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,895.65 |
| Travel and Lodging | $1,002.92 |
| Food and Beverage | $367.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $35,058.90 | 2021-2025 | Omnipod, Omnipod |
| Dexcom, INC. | $503.35 | 2021-2023 | Dexcom G6 Transmitter |
| Merz North America, INC. | $155.25 | 2023-2025 | Xeomin |
| Novo Nordisk INC | $60.56 | 2021-2024 | Wegovy |
| Lilly USA, LLC | $48.56 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.08 | 2022 | |
| Ibsa Pharma INC. | $17.20 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.